Skip to content
Catalyst

milk thistle extract (silymarin)Finding

Milk thistle extract (silymarin) decreases fasting blood glucose

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“Silymarin administration was associated with a significant reduction in fasting blood glucose levels (mean difference [MD] (−26.86 mg/dL; 95% CI [−35.42, −18.30])) in four trials.”
Quoted verbatim from Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
This finding among the 111 findings on its endpoint

milk thistle extract (silymarin)

Fasting blood glucose

lowers

Effect as reported

−26.86mean difference

CI −35.42 to −18.3

Who
Patients with type 2 diabetes mellitus; four pooled randomised controlled trials
Dose studied
silymarin 200 to 600 mg daily across the included trials

Moderate evidencePMID 27340676 · 2016

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Journal of diabetes research
What else it reported1 finding · 0 compounds · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y293BC4VJS1M417S85P4SE